Skip to main content
Log in

The endolymphatic sac tumor: challenges in the eradication of a localized disease

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Objective

Identify the critical points that lead to recurrences and lack of radicality in endolymphatic sac tumors (ELSTs).

Study design

Retrospective case study and review of the literature.

Setting

Tertiary referral center.

Patients

Thirteen cases of ELST were included in the study and their preoperative, intraoperative and postoperative data were analyzed and compared to a review of the literature.

Intervention(s)

Therapeutical.

Main Outcome Measure(s)

Prevalence of recurrent and residual tumors, comparison to the literature and analysis of ELST characteristics.

Results

Diagnosis was made 26 ± 17 months after the onset of symptomatology, and an ELST was preoperatively suspected in only six cases. At the time of surgery, 10 patients suffered from hearing loss. Preoperative symptoms or audiometry could not predict labyrinth infiltration, although speech discrimination scores were significantly associated with labyrinth infiltration (p = 0.0413). The labyrinth was infiltrated in 8 cases (57.1%), and in 7 cases (46.7%) the tumor eroded the carotid canal, whereas 6 cases (40%) presented an intradural extension. A gross total resection was achieved in 11 cases. There were two residual tumors, one of which because of profuse bleeding, and one recurrence (23.1%). A mean of 22.8% of recurrent or residual tumors are described in the literature based on 242 published cases, in more than half of the cases as a consequence of subtotal tumor resection (STR).

Conclusions

Recurrence derives mostly from the difficulty to identify the extension of the tumor due to the extensive bone infiltration. Accurate diagnosis and correct preoperative planning, with embolization when possible, will facilitate surgery and avoid STR due to intraoperative bleeding. Long follow-ups are important in order to avoid insidious recurrences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1 

Similar content being viewed by others

References

  1. Corrales CE, Mudry A (2017) History of the endolymphatic sac: from anatomy to surgery. Otol Neurotol 38(1):152–156

    PubMed  Google Scholar 

  2. Heffner DK (1989) Low-grade adenocarcinoma of probable endolymphatic sac origin. A clinicopathologic study of 20 cases. Cancer 64(11):2292–2302

    CAS  PubMed  Google Scholar 

  3. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World health organization classification of head and neck tumours. WHO Classif Tumour

  4. Roche PH, Dufour H, Figarella-Branger D, Pellet W (1998) Endolymphatic sac tumors: report of three cases. Neurosurgery 42(4):927–932

    CAS  PubMed  Google Scholar 

  5. Timmer FC, Neeskens LJ, van den Hoogen FJ, Slootweg PJ, Dunnebier EA, Pauw BK, Mulder JJ, Cremers CW, Kunst HP (2011) Endolymphatic Sac tumors: clinical outcome and management in a series of 9 cases. Otol Neurotol 32(4):680–685

    PubMed  Google Scholar 

  6. Hou ZH, Huang DL, Han DY, Dai P, Young WY, Yang SM (2012) Surgical treatment of endolymphatic sac tumor. Acta Otolaryngol 132(3):329–336

    PubMed  Google Scholar 

  7. Bastier PL, de Mones E, Marro M, Elkhatib W, Franco-Vidal V, Liguoro D, Darrouzet V (2013) Eur Arch Otorhinolaryngol 270(4):1551–1557

    PubMed  Google Scholar 

  8. Kim HJ, Hagan M, Butman JA, Baggenstos M, Brewer C, Zalewski C, Linehan WM, Lonser RR (2013) Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications. Laryngoscope 123(2):477–483

    PubMed  Google Scholar 

  9. Butman JA, Nduom E, Kim HJ, Lonser RR (2013) Imaging detection of endolymphatic sac tumor-associated hydrops. J Neurosurg 119(2):406–411

    PubMed  Google Scholar 

  10. Husseini ST, Piccirillo E, Taibah A, Paties CT, Almutair T, Sanna M (2013) The Gruppo Otologico experience of endolymphatic sac tumor. Auris Nasus Larynx 40(1):25–31

    PubMed  Google Scholar 

  11. Carlson ML, Thom JJ, Driscoll CL, Haynes DS, Neff BA, Link MJ, Wanna GB (2013) Management of primary and recurrent endolymphatic sac tumors. Otol Neurotol 34(5):939–943

    PubMed  Google Scholar 

  12. Friedman RA, Hoa M, Brackmann DE (2013) Surgical management of endolymphatic sac tumors. J Neurol Surgery, Part B Skull Base 74(1):12–19

    Google Scholar 

  13. Nevoux J, Nowak C, Vellin JF, Lepajolec C, Sterkers O, Richard S, Bobin S (2014) Management of endolymphatic sac tumors: Sporadic cases and von Hippel-Lindau disease. Otol Neurotol 35(5):899–904

    PubMed  Google Scholar 

  14. Poletti AM, Dubey SP, Colombo G, Cugini G, Mazzoni A (2016) Treatment of endolymphatic sac tumour (Papillary adenocarcinoma) of the temporal bone. Reports Pract Oncol Radiother 21(4):391–394

    Google Scholar 

  15. Megerian CA, Haynes DS, Poe DS, Choo DI, Keriakas TJ, Glasscock ME (2002) Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol 23(3):378–387

    PubMed  Google Scholar 

  16. Zanoletti E, Girasoli L, Borsetto D, Opocher G, Mazzoni A, Martini A (2017) Endolymphatic sac tumour in von hippel-lindau disease: management strategies. Acta Otorhinolaryngol Ital 37(5):423–429

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Le H, Zhang H, Tao W, Lin L, Li J, Ma L, Hong G, Lou X (2019) Clinicoradiologic characteristics of endolymphatic sac tumors. Eur Arch Oto-Rhino-Laryngology 276(10):2705–2714

    Google Scholar 

  18. Thompson LDR, Magliocca KR, Andreasen S, Kiss K, Rooper L, Stelow E, Wenig BM, Bishop JA (2019) CAIX and pax-8 commonly immunoreactive in endolymphatic sac tumors: a clinicopathologic study of 26 cases with differential considerations for metastatic renal cell carcinoma in von Hippel-Lindau patients. Head Neck Pathol 13(3):355–363

    PubMed  Google Scholar 

  19. Bae SH, Kim S, seob, Kwak SH, Jung JS, Choi JY, Moon IS, (2020) Clinical features and treatment of endolymphatic sac tumor. Acta Otolaryngol 140(6):433–437

    PubMed  Google Scholar 

  20. Rodrigues S, Fagan P, Turner J (2004) Endolymphatic sac tumors a review of the St.Vincent’s Hospital experience. Otol Neurotol. 25(4):599–603

    PubMed  Google Scholar 

  21. Hansen MR, Luxford WM (2004) Surgical outcomes in patients with endolymphatic sac tumors. Laryngoscope 114(8I):1470–1474

    PubMed  Google Scholar 

  22. Schipper J, Maier W, Rosahl SK, van Velthoven V, Berlis A, Boedeker CC, Laszig R, Teszler CB, Ridder GJ (2006) Endolymphatic sac tumours: surgical management. J Otolaryngol 35(6):387–394

    PubMed  Google Scholar 

  23. Doherty JK, Yong M, Maceri D (2007) Endolymphatic sac tumor: a report of 3 cases and discussion of management. Ear Nose Throat J 86(1):30–35

    PubMed  Google Scholar 

  24. Diaz RC, Amjad EH, Sargent EW, LaRouere MJ, Shaia WT (2007) Tumors and pseudotumors of the endolymphatic sac. Skull Base 17(6):379–394

    PubMed  PubMed Central  Google Scholar 

  25. Ni Y, Wang S, Huang W, Jiang H, Zhang T, Wang Y, Wang Z, Li H (2008) Surgery for endolymphatic sac tumor: whether and when to keep hearing? Acta Otolaryngol 128(9):976–983

    PubMed  Google Scholar 

  26. Codreanu C, Tran Ba Huy P (2010) Isolate vertigo crisis revealing an endolymphatic sac tumor. Rom J Morphol Embryol 51(2):387–389

    CAS  PubMed  Google Scholar 

  27. Kawahara N, Kume H, Ueki K, Mishima K, Sasaki TKT (1999) VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology 53(1):208

    CAS  PubMed  Google Scholar 

  28. Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22(24):4991–5004

    CAS  PubMed  Google Scholar 

  29. Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, Lebovics R, Sledjeski K, Choyke PL, Zbar B, Linehan WM, Oldfield EH (1997) Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel- Lindau disease. J Am Med Assoc 277(18):1461–1466

    CAS  Google Scholar 

  30. Bausch B, Wellner U, Peyre M et al (2016) Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the international endolymphatic sac tumor registry. Head Neck. 38(Suppl 1):E673–E679

    PubMed  Google Scholar 

  31. Bambakidis NC, Megerian CA, Ratcheson RA (2004) Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol 25(5):773–781

    PubMed  Google Scholar 

  32. House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol - Head Neck Surg 93(2):146–147

    CAS  PubMed  Google Scholar 

  33. Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH (2000) Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19(48):5435–5443

    CAS  PubMed  Google Scholar 

  34. Albiñana V, Escribano RMJ, Soler I, Padial LR, Recio-Poveda L, Gómez V, de Las HK, Botella LM (2017) Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. Orphanet J Rare Dis 12(1):1–10

    Google Scholar 

  35. Jensen RL, Gillespie D, House P, Layfield L, Shelton C (2004) Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1α expression. J Neurosurg 100(3):488–497

    CAS  PubMed  Google Scholar 

  36. Bambakidis NC, Rodrigue T, Megerian CA, Ratcheson RA (2005) Endolymphatic sac tumor metastatic to the spine. Case report J Neurosurg Spine 3(1):68–70

    PubMed  Google Scholar 

  37. Tay KY, Yu E, Kassel E (2007) Spinal metastasis from endolymphatic sac tumor. Am J Neuroradiol 28(4):613–614

    CAS  PubMed  Google Scholar 

  38. Mendenhall WM, Suárez C, Skálová A, Strojan P, Triantafyllou A, Devaney KO, Williams MD, Rinaldo A, Ferlito A (2018) Current treatment of endolymphatic sac tumor of the temporal bone. Adv Ther 35(7):887–898

    PubMed  Google Scholar 

  39. Prasad SC, Piras G, Piccirillo E, Taibah A, Russo A, He J, Sanna M (2017) Surgical strategy and facial nerve outcomes in petrous bone cholesteatoma. Audiol Neurotol 21(5):275–285

    Google Scholar 

  40. Prasad SC, Laus M, Dandinarasaiah M, Piccirillo E, Russo A, Taibah A, Sanna M (2018) Surgical management of intrinsic tumors of the facial nerve. Neurosurgery 83(4):740–752

    PubMed  Google Scholar 

  41. Sbaihat A, Bacciu A, Pasanisi E, Sanna M (2013) Skull base chondrosarcomas: surgical treatment and results. Ann Otol Rhinol Laryngol 122(12):763–770

    PubMed  Google Scholar 

  42. Brackmann DE, Teufert KB (2006) Chondrosarcoma of the skull base: long-term follow-up. Otol Neurotol 27(7):981–991

    PubMed  Google Scholar 

  43. Sinclair G, Al-Saffar Y, Brigui M, Martin H, Bystam J, Benmakhlouf H, Shamikh A, Dodoo E (2018) Gamma knife radiosurgery in the management of endolymphatic sac tumors. Surg Neurol Int 9:18

    PubMed  PubMed Central  Google Scholar 

  44. Balasubramaniam S, Deshpande RB, Misra BK (2009) Gamma knife radiosurgery in jugular foramen endolymphatic sac adenocarcinoma. J Clin Neurosci 16(5):710–711

    PubMed  Google Scholar 

  45. Megerian CA, McKenna MJ, Nuss RC, Maniglia AJ, Ojemann RG, Pilch BZ, Nadol JB Jr (1995) Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von hippel-lindau disease. Laryngoscope 105(8 Pt 1):801–808

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vittoria Sykopetrites.

Ethics declarations

Conflict of interest

The study was done at the Gruppo Otologico, a quaternary referral center for neurotology and skull base surgery. There is no conflict of interest involved, and the present work has not received any funding from any sources.

Ethical statement

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

The study was approved by our Institutional Review Board. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article. However, the article does not contain any direct information regarding patient identity.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sykopetrites, V., Piras, G., Giannuzzi, A. et al. The endolymphatic sac tumor: challenges in the eradication of a localized disease. Eur Arch Otorhinolaryngol 278, 2297–2304 (2021). https://doi.org/10.1007/s00405-020-06323-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-020-06323-x

Keywords

Navigation